A New Jersey district court judge showed signs that he, like other judges before him, may also be skeptical of drug industry allegations that the new Medicare drug price negotiation program is unconstitutional -- whether it be allegations that it compels drug makers to agree to negotiate lower prices for their products or permits the government to take manufacturers’ private, patented drugs without providing just compensation -- as four drug makers presented oral arguments before the district court on March...